drugset / Trial / NCT00043043

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

NCT00043043 ↗

RandomizedDouble-blindPrevention

Summary

RATIONALE: Celecoxib may be effective in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia. PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia.

Timeline

Start
2003-05
Primary completion
—
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral

Indications